Project description
New implant to treat cataracts
With age comes… cataracts. Very common in older people, cataracts cause clouding of the eye's lens, affecting vision. Despite innovations in the domain of ophthalmological implants, called intraocular lenses, cataract patients do not regain sharp and continuous vision. New ophthalmic implants patented by France’s Cristalens Industrie could reverse this trend. The EU-funded SYMBIOSE project will validate this new implant to prepare for its commercialisation. Specifically, the project will collect enough data to demonstrate high performance by testing on several hundred patients. The project will also prepare for scaling up production and support the wide distribution of the products.
Objective
When getting older, everyone suffers from a loss of visual continuity, either from presbyopia or opacification of the eye’s lens (called cataract). What’s more, cataract surgery likewise leads to presbyopia. Despite continual innovation in the domain of ophthalmological implants called IOLs (intraocular lens), cataract patients do not recuperate sharp and continuous vision.
Today, choosing an IOL is a question of constraints and compromises for both the surgeon and the patient.
These problems can be relegated to the past thanks to the SYMBIOSE IOLs portfolio. SYMBIOSE IOLs are ophthalmic implants integrating a continuous phase optical profile, patented by Cristalens Industrie. SYMBIOSE IOLs allow continuous, quality vision in all daily activities.
In order to validate this product and go to market, Cristalens Industrie faces a twofold challenge:
- clinical, to collect enough data demonstrating the complete system’s high performance and thus convince Key Opinion Leaders worldwide,
- industrial, to deploy the innovation in a product portfolio and ensure the scale-up of production, intellectual property, regulatory and marketing issues.
These challenges define Cristalens Industrie's work program which includes four work packages in addition to management:
1/ Demonstrate the performance of the complete system in 300 patient cases,
2/ Prepare to scale up to ensure manufacturing capacity meets customer demand,
3/ Convince the scientific and medical community,
4/ Remove regulatory barriers and secure IP aspects.
Cristalens Industrie aims to establish itself as the innovative leader for the next generation of IOLs.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine surgery
- medical and health sciences medical biotechnology implants
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-2 - SME instrument phase 2
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
22300 Lannion
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.